The European Commission on Wednesday (April 11) approved its decision on the first approved European Union drug for erectile dysfunction (ED) with sildenafil, the first erectile dysfunction drug to be approved in more than a decade.
This approval follows a similar decision of the European Medicines Agency (EMA) for the treatment of pulmonary arterial hypertension, an in which the EMA has recommended that sildenafil be the first non-surgical treatment for erectile dysfunction.
“The decision on the first approved drug for erectile dysfunction with sildenafil is a strong and timely one in the EU,” EMA President and CEO Emanuele Fanardi said in a statement.
“It will help improve patients’ quality of life and reduce the cost of ED treatment,” he added. “It will also help patients pay for their medications.”
A sildenafil tablet, marketed under the name Viagra, is one of the most widely used drugs for erectile dysfunction. The drug works by relaxing blood vessels in the penis, allowing more blood to flow into the penis when sexually excited. However, it can also cause side effects such as headaches, muscle pain, flushing, dizziness, and low blood pressure.
Efficacy of the treatment was measured by a questionnaire and a comparison of the results. Viagra users reported a significant improvement in their erectile function compared to the placebo.
The drug has already been approved by the European Medicines Agency (EMA) for treatment of erectile dysfunction in more than a decade.
The EMA on Wednesday (April 11) approved the first approved EU drug for erectile dysfunction with sildenafil, the first non-surgical treatment for erectile dysfunction.
Elderly patients aged 65 and above who had been prescribed sildenafil to treat ED are not advised to use it.
Image credit: Alastair HensleyElderly patients aged 65 and over who had been prescribed sildenafil to treat ED are not advised to use it.
IMPORTANT NOTICE: Please be aware, prior to sale, you are advised to have a short phone call consultation with our Pharmacist. Automatic purchase consents the Pharmacist to give you a quick call.
Viagra Connect is available without a Prescription but requires a brief consultation with the Pharmacist. It is available in a 4 pack or an 8 pack. Viagra Connect contains Sildenafil 50mg which works by relaxing the penis blood vessels, allowing blood to flow when you get aroused causing erections and potency. Viagra Connect will only help men become erect if you are aroused. Only for adult use, men 18 years plus.
How to be taken:
VIAGRA CONNECT is not to be taken if:
Please read instructions carefully provided.
Viagra Connect is a fast acting drug for erectile dysfunction which can last up to 4 hours and takes effect within 30 minutes after administration.
Sildenafil Citrate 50 mg Tablets: This tablet is specifically formulated to treat the symptoms of erectile disfunction and is highly effective in treating it, the most common sexual disorder affecting men over the age of 40 years. Provides a solution to erectile dysfunction in men who suffer from impotence due to conditions such as heart disease or diabetes, or who have problems with their physical or mental health.
Viagra Connect ensures fast and effective results that last as long as 36 hours and come without side effects. It works by relaxing the blood vessels in the penis, allowing blood to flow into the phallus when you get sexually excited and causing the desired stiffness.
Add another method to erectile dysfunction treatment. Sildenafil belongs to a group of medicines known as phosphodiesterase type 5 (PDE5) inhibitors. It is used to treat several different conditions such as:Viagra Connect is a PDE5 inhibitor which works by relaxing the blood vessels in the penis, allowing blood to flow into the penis when you get sexually excited and causing the desired stiffness. This means that it can help you with erectile dysfunction after a traumatic event such as a sexual abuse or relationship relationship.
Viagra Connect ensures fast and effective results that last as long as 4 hours. It works by relaxing the blood vessels in the penis, allowing blood to flow into the penis when you get sexually excited and causing the desired stiffness.
Sildenafil Citrate 50 mg Tablets: This tablet is specifically formulated to treat the symptoms of erectile dysfunction and is highly effective against the conditions which cause erectile dysfunction.
Viagra, the well-known brand of Viagra, is offering you a discount card for the first time. The card will be used for a new website. We are offering the first discount on the website that is sold for the first time. This is an offer for all customers. You can take advantage of this offer by clicking the link below: Viagra discount card. We are offering you this discount card on the first page of the website. Then, you will be able to use the discount card on the second page of the website. You will be able to get a discount on the website from our customers at any time. The discount card will be accepted at any time. You will be able to use it from the second page of the website.
We are offering you a discount card on the first page of the website. The discount card is accepted at any time. You will be able to use it at any time. We are offering you the discount card on the second page of the website. We are offering you the discount card on the first page of the website.
Viagra discount cardThe Viagra card will be accepted at any time. The card will be accepted at any time. Viagra is now available to purchase for those who may not be able to access it in the future. Viagra will now be available for purchase to those who may be able to access it.
Viagra is now available for purchase for those who may not be able to access it in the future. Viagra will now be available for purchase to those who are able to access it.
Viagra discount codeYou can take advantage of this offer by clicking the link below: Viagra discount code. We are offering you the first discount on the website. You can take advantage of it at any time.
The discount code will be accepted at any time. The discount code is accepted at any time. We are offering you the discount code on the first page of the website.
By
WASHINGTON — The U. S. Department of Health and Human Services says it has reached a deal with Pfizer Inc. to let the company provide generic versions of erectile dysfunction drugs without a prescription. Under the agreement, Pfizer will pay the Department of Health and Human Services $25 million to resolve allegations that it is conspiring to violate the federal Health Insurance Portability and Accountability Act and the False Claims Act, and that it failed to disclose any of the terms of its deal.
The deal was announced by the Department of Health and Human Services’ Office on Wednesday afternoon. It comes as the U. Department of Health and Human Services continues to closely monitor and investigate allegations that Pfizer Inc. is colluding to influence and delay the approval of erectile dysfunction drugs such as Viagra and Cialis. The Department of Health and Human Services said it would not release details of its investigation until after the deadline for its initial report. In its latest quarterly report, Pfizer said it is aware of allegations and that it does not intend to make any disclosures in the report.
“Pfizer has no intention of changing its business relationship with the Department of Health and Human Services, and we will continue to do everything we can to ensure that the Department of Health and Human Services is doing its utmost to keep Pfizer accountable and that the Department is doing its utmost to ensure that the health and safety of its members and staff remains protected,” said David A. Butts, secretary of health and human services. “I am satisfied that Pfizer is doing everything we can to ensure that the Department of Health and Human Services is doing its utmost to keep the pharmaceutical industry safe.”
In the report, the Department’s Office on the Department of Health and Human Services found that Pfizer’s actions in the past were closely monitored by the health and human services department and that the Department of Health and Human Services does not intend to release any details of its investigation. The Department has not yet released its detailed investigation, however, which includes three key findings.
In a letter posted to the Department of Health and Human Services on Wednesday afternoon, the Department of Health and Human Services said it has received an email from Pfizer requesting information from the Office on the Department of Health and Human Services. The letter stated that the Department has received information from Pfizer in relation to the investigation, and that the Department of Health and Human Services has “no plans” to provide information to the press about what Pfizer did to influence the investigation. “The Department of Health and Human Services has no plans to release any information about its investigation,” the letter said.
The Department of Health and Human Services said it has concluded that there was no agreement between Pfizer and the Department of Health and Human Services, that there was no communication of any kind between Pfizer and the Department of Health and Human Services, and that the Department of Health and Human Services “has no intention” to release any information about the investigation.
Pfizer’s allegations in the letter “are not credible,” said the letter. The letter said that in a letter dated July 3, 2006, Pfizer’s counsel stated that “we do not have any information regarding the company’s efforts to influence the investigation. We will continue to share this information with the Department of Health and Human Services.”
Pfizer’s allegations were “not supported by the evidence,” the letter said. In its letter to the Department of Health and Human Services, Pfizer said it does not intend to make any disclosures in relation to its investigation. However, Pfizer’s response to the letter said that the Department of Health and Human Services “is continuing to take all reasonable steps to ensure that its employees are being held accountable and liable for their own professional conduct.”
Pfizer’s investigation has not been concluded and the Department of Health and Human Services has not yet released its investigation. Pfizer continues to be aware of its allegations in the letter and the Department of Health and Human Services’ response to the letter.
“Pfizer’s actions in the past, and its commitment to the Department of Health and Human Services, are part of a larger effort to protect the public and to provide adequate and effective care to our employees,” said Butts in the letter. “We will continue to share this information with the Department of Health and Human Services.
GST Registration Date01-07-2017
Legal Status of FirmProprietorship
Nature of BusinessWholesaler/Distributor
Number of Employees26 To 50 People
Annual Turnover5 - 25 Cr
IndiaMART Member SinceDec 2011
GST07AAIPG2896A1ZV
Import Export Code (IEC)05140*****
Exports toUnited States Of America | Australia | United Kingdom | Canada | Saudi Arabia
MEDISELLER®is Govt-certifiedGlobal Exporter, All-India Wholesaler & Retailerof all 100% authentic Pharmaceutical Products. Our team has created aglobal network of more than 150,000 patients & doctors in 23 countries. We specialise in procuring 100% authentic products from reputedmanufacturers like GSK, PLC, NDC, Aurobindo,anta Boots,brainer,anta Well, Dubai International, G& W, J& A, Zydus Pharm, Pfizer, among others.Our team comprises of managers who understand theprospect for customers, specific needs, upcoming deals, side effects, & moreand our team has a extensive knowledge ofall the medicines,including Viagra, Cialis, Levitra, Staxyn, Stendra, Cialis, generic Cialis, Stendra, Stendra, generic Cialis, Stendra, generic Staxyn, Staxlou, Stendra, Stendra, Stendra, Staxyn, Staxlovate, Stavrosquinat, Sanofi, and many many others.Our team believes in offering high quality products with excellenteffectiveness,an excellentlow risk of------------------------------------discretion, reliability, speed, and deliverability.Their commitment is to deliver thebest possible price, offering you theguaranteed experiences,an outstanding range of products, highly effective in procuringall the available authentic medicines.